View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Vaccination News

SPONSORED CONTENT
Save
SPONSORED CONTENT
February 18, 2022
2 min read
Save

Review outlines common allergic reactions, testing protocols following vaccination

Review outlines common allergic reactions, testing protocols following vaccination

Delayed hypersensitivity to vaccines is not uncommon but also does not typically contraindicate further vaccination, and patch testing can be used to determine the cause, according to a study published in Allergy & Asthma Proceedings.

SPONSORED CONTENT
February 17, 2022
1 min read
Save

AAP launches video series addressing questions about childhood vaccines

AAP launches video series addressing questions about childhood vaccines

In its latest public campaign to encourage parents to vaccinate their children, the AAP launched a new series of videos that address common questions parents have about childhood vaccines.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
February 16, 2022
1 min read
Save

Among youngest kids, hospitalization rates five times higher during omicron vs. delta

Among youngest kids, hospitalization rates five times higher during omicron vs. delta

COVID-19 hospitalization rates among children aged 0 to 4 years in the U.S. were around five times higher during the peak of the omicron wave compared with the peak of the delta wave, researchers reported in MMWR.

SPONSORED CONTENT
February 15, 2022
1 min read
Save

Top in ID: Protective effect of prior SARS-CoV-2 infection, FDA approval of HIV regimen

Top in ID: Protective effect of prior SARS-CoV-2 infection, FDA approval of HIV regimen

Patients who were infected with SARS-CoV-2 were protected against symptomatic reinfection with SARS-CoV-2 variants, including omicron, according to a recent study. It was the top story in infectious disease last week.

SPONSORED CONTENT
February 14, 2022
2 min read
Save

Data suggest PCPs ‘play critical role in ensuring vaccine acceptance’

Data suggest PCPs ‘play critical role in ensuring vaccine acceptance’

Counties in the United States with the highest number of primary care physicians also had the highest COVID-19 vaccination rates, a cross-sectional study showed.

SPONSORED CONTENT
February 14, 2022
27 min watch
Save

VIDEO: ‘We really do need more research’ on link between COVID-19 vaccination and tinnitus

VIDEO: ‘We really do need more research’ on link between COVID-19 vaccination and tinnitus

Researchers are exploring a potential link between COVID-19 vaccination and tinnitus.

SPONSORED CONTENT
February 11, 2022
2 min read
Save

FDA postpones review of Pfizer vaccine for kids under 5, citing new data

FDA postpones review of Pfizer vaccine for kids under 5, citing new data

Citing the emergence of new data, the FDA on Friday announced that it has postponed a meeting scheduled for next week in which an advisory panel would have discussed Pfizer and BioNTech’s COVID-19 vaccine for kids aged younger than 5 years.

SPONSORED CONTENT
February 11, 2022
2 min read
Save

'Too early' to lift mask mandates in schools, AAP says

'Too early' to lift mask mandates in schools, AAP says

The Democratic governors of several states, including New Jersey and Delaware, announced this week that they will soon lift COVID-19 mask mandates in K-12 schools, joining other states that have already eliminated such measures.

SPONSORED CONTENT
February 10, 2022
2 min read
Save

Novavax reports 80% efficacy in adolescent COVID-19 vaccine trial

Novavax reports 80% efficacy in adolescent COVID-19 vaccine trial

Novavax on Thursday announced that its COVID-19 vaccine was around 80% effective among adolescents aged 12 to 17 years in a phase 3 trial.

SPONSORED CONTENT
February 08, 2022
1 min read
Save

Top in ID: Moderna vaccine approval, efficacy of N95 and KN95 masks

Top in ID: Moderna vaccine approval, efficacy of N95 and KN95 masks

The FDA recently approved Moderna’s COVID-19 vaccine, which will be branded in the U.S. as Spikevax. The announcement was the top story in infectious disease last week.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails